Delivery Order SPE2DB22D3501-SPE2DB23FXE36
Award Date 9/14/23
Potential Completion Date 10/5/23
Potential Value $157K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $5,242 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562168451 units of Xeomin 200 unit vials. The one-month contract will provide botulinum toxin type A to support Defense Department programs and runs from September 12 to October 3, 2023. Amerisourcebergen will fulfill the order from its Conshohocken, Pennsylvania facility. No subcontractors or set aside designations were specified. The Defense Logistics Agency manages the...
- The Defense Logistics Agency awarded a $9,288.60 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562199420 units of Xeomin 100 unit vials. As the prime contractor, Amerisourcebergen will deliver the botulinum toxin type A injection to its place of performance in Conshohocken, Pennsylvania by October 6, 2023 to support Department of Defense requirements. No subcontractors or set aside designations were identified. The delivery order was issued against an existing DLA...
- The Defense Logistics Agency awarded a $22,018 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 vials of Xeomin. To be performed in Conshohocken, Pennsylvania from September 29th through October 23rd, 2023, this order is in support of the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were specified. The award utilizes an existing DLA medical product contract vehicle to procure this botulinum toxin, supporting the...
- The Defense Logistics Agency awarded a $44,036 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 200 vials of Xeomin. To be performed in Conshohocken, Pennsylvania from August 29th to September 20th, 2023, this order is placed against an existing DLA contract vehicle to supply the agency with pharmaceutical products in support of Department of Defense operations. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the botulinum toxin directly to DLA...
- The Defense Logistics Agency awarded a $8,092.40 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division for the purchase of 100 units of Xeomin 100 unit vials. The prime contractor will deliver the botulinum toxin type A injection product to the specified location in Conshohocken, Pennsylvania by August 24, 2023 to support Defense Logistics Agency programs. No subcontractors or set aside designations were identified for this delivery order placed under an...
- The Defense Logistics Agency awarded a $10,484.80 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 vials of Xeomin. The order is to be performed in Conshohocken, Pennsylvania from August 18th through September 11th, 2023. As the prime contractor, Amerisourcebergen Drug Corporation will supply the botulinum toxin type A injection to the Defense Logistics Agency, the logistics combat support agency of the United States Department of Defense, in support of its medical...
- The Defense Logistics Agency awarded a $23,590.80 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 vials of Xeomin. As the prime contractor, Amerisourcebergen will deliver the botulinum toxin to its place of performance in Conshohocken, Pennsylvania by July 20th, 2023 to fulfill DLA's requirements. No subcontractors or set aside designations were indicated. This contract supports DLA's medical supply procurement programs and will provide the U.S. military with needed...
- The Defense Logistics Agency awarded a $5,471.20 firm fixed price delivery order to Amerisourcebergen Drug Corp for 50 units of Xeomin 50 unit vials. Performance will take place in Conshohocken, Pennsylvania, with no set-aside designation specified. Amerisourcebergen Drug Corp is a division of Amerisourcebergen Corporation, which will provide the botulinum toxin injection vials in support of the Defense Logistics Agency's medical supply procurement programs. The delivery order was awarded on...
- The Defense Logistics Agency awarded a $13,106 delivery order to Amerisourcebergen Drug Corporation for 200 vials of Xeomin. The firm fixed price order is being fulfilled from Amerisourcebergen's Conshohocken, Pennsylvania location to support Defense Logistics Agency requirements. No subcontractors or set aside designations were identified. The delivery order was issued against an existing DLA contract vehicle to procure this botulinum toxin medication for the agency's medical supply needs....
- The Defense Logistics Agency awarded a $10,484.80 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 200 units of Xeomin, a botulinum toxin used for medical purposes. Performance will take place in Conshohocken, Pennsylvania over a four week period concluding in mid-September 2023. The prime contractor, Amerisourcebergen Drug Corporation, will supply the botulinum toxin products to the DLA, the Department of Defense's logistics combat support agency, in support of the...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB23FXE36Delivery Order
The Defense Logistics Agency awarded a $157,272 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562185243 units of Xeomin 100 unit vials. The prime contractor, Amerisourcebergen Drug Corporation, will deliver the botulinum toxin type A vials from its Conshohocken, Pennsylvania facility to support DLA requirements. No subcontractors or set aside designations were identified. The one month period of performance from September 14 to October 5, 2023 aligns with DLA's mission to provide medical supplies and equipment to the U.S. military and other government agencies.
Generated 12/23/23, 6:04 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $157.3k | 9/14/23 |